Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
MUMC+ kan hersentumoren in beeld brengen in één onderzoek
mei 2021 | Neuro-oncologie